Today: 20 May 2026
UOB stock slips in Singapore after JPMorgan downgrade — here’s what investors watch next
26 January 2026
1 min read

UOB stock slips in Singapore after JPMorgan downgrade — here’s what investors watch next

Singapore, Jan 26, 2026, 14:51 SGT — Regular session

  • UOB shares fell 2.7% to S$38.45 in afternoon trading, underperforming other local banks
  • JPMorgan downgraded UOB to “underweight” but left its target price steady at S$34
  • Attention shifts to UOB’s full-year results for Feb 24

United Overseas Bank Ltd (UOB) shares dropped on Monday, falling 2.66% to S$38.45 by 2:48 p.m. local time, after touching a high of S$39.20 earlier. The Straits Times Index in Singapore dipped 0.69%. DBS shares slipped 0.8%, while OCBC dropped 1.22%.

The pullback follows UOB’s record close on Friday, but selling pressure emerged after JPMorgan downgraded the stock, The Business Times reported. JPMorgan shifted its rating from “neutral” to “underweight,” signaling expectations that the stock will underperform its peers, while maintaining a target price of S$34, the report added. The Business Times

JPMorgan told The Edge Singapore it doesn’t expect asset quality concerns to be fully resolved by 4Q2025. It also ranked UOB behind DBS and OCBC in a new “pecking order.” The bank pointed to risks from commercial real estate, rising credit costs in Thailand, and tighter liquidity in Indonesia as reasons UOB’s shares could lose steam after a strong rally. The Edge Singapore

At the moment, this appears more like profit-taking disguised as something else. UOB had been a top performer among Singapore’s banks, and Monday’s dip is cutting back on those gains—though it’s far from wiping them out.

Traders are keeping an eye on whether the selling spreads across the sector. Singapore’s major lenders have been trading more in unison recently, and because UOB carries significant weight, any sharp move there can quickly impact the benchmark.

The downside scenario is clear. If loan demand weakens, funding costs hit harder than anticipated, or provisions climb once more, the stock could slide further—even without fresh headlines.

The next major trigger is coming up fast: UOB is set to report its full-year 2025 results on Feb 24, ahead of market open, according to a filing with the Singapore Exchange.

Investors will focus on any changes in comments about asset quality, updates on credit cost forecasts, and management’s stance on capital and shareholder returns.

For now, the tape speaks for itself — and if broker downgrades extend past JPMorgan, it might signal more than a brief breather after a record run, potentially marking the start of a broader reset ahead of earnings.

Stock Market Today

  • Sea Limited (NYSE:SE) Valuation Under Scrutiny After 46% One-Year Share Decline
    May 20, 2026, 10:05 AM EDT. Sea Limited (NYSE:SE), active across e-commerce, digital financial services, and digital entertainment in Southeast Asia and Latin America, has seen its stock fall by 46.26% over the past year. Despite recent share price weakness, some analysts argue the stock trades 36.6% below a $137.64 fair value estimate, buoyed by strong revenue growth from Shopee, Monee, and Garena platforms. Key drivers include accelerating mobile internet penetration, youth digital literacy, and shifts toward cashless payments supporting loan book expansion and improved monetization. Market watchers debate whether this dip offers a buying opportunity or reflects tempered growth prospects, especially as Shopee faces competitive pressures. Investors should weigh Sea's potential for earnings growth against market realities and execution risks.

Latest articles

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

20 May 2026
Vida Global Inc. raised $15 million in its May 18 IPO, selling 3.75 million shares at $4 each, but the stock closed at $2.29 on Tuesday. CEO Lyle Pratt bought 312,900 shares for about $1.19 million, according to a Form 4 filing. Vida reported 2025 revenue of $551,383 and a net loss of $2.9 million. The company’s shares trade on NYSE American and NYSE Texas under the symbol VIDA.
TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

20 May 2026
TJX raised its fiscal 2027 sales, earnings, and buyback targets after first-quarter comparable sales rose 6% and net income hit $1.3 billion. Shares climbed 3.6% in premarket trading. The company cited higher fuel costs as a drag on its full-year forecast. Marmaxx, HomeGoods, and TJX Canada all posted strong sales growth.
ImmunityBio in the Spotlight with Patents and BCG Deal Ahead of the Open

ImmunityBio Faces FDA Decision on Bladder-Cancer Application, Risk Remains

20 May 2026
The FDA accepted ImmunityBio’s application to expand Anktiva’s use with BCG in papillary-only, BCG-unresponsive non-muscle invasive bladder cancer, setting a Jan. 6, 2027 decision date. ImmunityBio reported $44.2 million in first-quarter net product revenue and held $380.9 million in cash and equivalents. Shares last traded at $7.76, down 2.8%. The filing is supported by data from 80 patients in a Phase 2/3 trial.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz
Previous Story

Stock Market Today 26.01.2026

Netflix to Paramount: Your Warner Bros bid “doesn’t pass the sniff test” as takeover clock ticks
Next Story

Netflix to Paramount: Your Warner Bros bid “doesn’t pass the sniff test” as takeover clock ticks

Go toTop